Condition: Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus · Sponsor: DualityBio Inc.
A Phase 1/2a Study of DB-2304 in Healthy Participants and Participants with Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus
This description comes directly from the study's public registry record.
Sally Li · +86 13910863858 · sally.li@dualitybiologics.com
Cong Zhang
Always discuss trial participation with your own doctor first.
| US06-0 | La Palma, California, United States | Recruiting |
| US03-0 | Clearwater, Florida, United States | Recruiting |
| US05-0 | Orlando, Florida, United States | Recruiting |
| US08-0 | Syracuse, New York, United States | Not Yet Recruiting |
| US04-0 | Irving, Texas, United States | Recruiting |
| US02-0 | San Antonio, Texas, United States | Recruiting |
| Site AUS01-0 | Melbourne, Victoria, Australia | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06625671